EUVIMEDEUVIMED entdecken
FallberichtLeserbriefOpen Access

Anifrolumab to treat a monogenic interferonopathy

Mohammad-Ali Doroudchi, Timothy J Thauland, Bhavita A Patel, Manish J Butte

The Journal of Allergy and Clinical Immunology: In Practice · 2024-05 · 12 (5) · 1374-1376.e1

DOI: 10.1016/j.jaip.2024.02.013 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024-05. Verfasst von Mohammad-Ali Doroudchi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, UCLA, Jeffrey Modell Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedHumansAntibodies, MonoclonalInterferonsMutation

Substanzen

anifrolumabAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedInterferons

Autor:innen und Institutionen

  • Division of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif.
  • Division of Hematology and Oncology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif; Miller Children's and Women's Hospital, Long Beach, Calif.
  • Division of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, Calif; Department of Microbiology, Immunology, and Molecular Genetics, University of Califo…

Förderung

  • NIAID NIH HHS
  • UCLA
  • Jeffrey Modell Foundation

Zitieren

APA

Doroudchi, M. A., Thauland, T. J., Patel, B. A., & Butte, M. J. (2024). Anifrolumab to treat a monogenic interferonopathy. The Journal of Allergy and Clinical Immunology: In Practice, 12(5), 1374-1376.e1. https://doi.org/10.1016/j.jaip.2024.02.013

Vancouver

Doroudchi MA, Thauland TJ, Patel BA, Butte MJ. Anifrolumab to treat a monogenic interferonopathy. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(5):1374-1376.e1. doi:10.1016/j.jaip.2024.02.013

BibTeX
@article{Doroudchi2024,
  author = {Doroudchi, Mohammad-Ali and Thauland, Timothy J and Patel, Bhavita A and Butte, Manish J},
  title = {Anifrolumab to treat a monogenic interferonopathy},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2024},
  volume = {12},
  number = {5},
  pages = {1374--1376.e1},
  doi = {10.1016/j.jaip.2024.02.013}
}
Kostenlos starten →